Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2021-10-06 00:00:00 ET · period of report 2021-10-04 · accession 0001437749-21-023375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-06 | 2021-10-04 | PBYI | AUERBACH ALAN H | Pres, CEO, Dir, 10% | S - Sale | $6.15 | -1,858 | 4.42M | -0.0% | -$11.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-04 | S | D | 1,858 | $6.15 | 4,415,932 | D | — | — |